Challenges in prescribing DOACs for stroke prevention in AF5' education - Mar. 2, 2020 - Prof. Freek Verheugt (Amsterdam, The Netherlands) and John Eikelboom (Hamilton, ON, Canada)
Video navigation menu
- Use of correct dosing of DOACs 00:30
- Underuse of DOACs 03:08
- Antidotes for DOACs 04:33
Should all AF patients on VKA, without contra-indication for DOACs, be switched to a DOAC?
Prof. Freek Verheugt, cardiologist, Amsterdam, The Netherlands
John Eikelboom, Associate Professor in the Department of Medicine at McMaster University, Hamilton, Ontario, Canada
This recording was independently developed under auspices of PACE-cme and funded by an unrestricted grant provided by Boehringer Ingelheim. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.